Rhythm says oral rare obesity drug clears Phase 2 test, plans tweaks to formulationnews2025-07-09T12:00:35+00:00July 9th, 2025|Endpoints News|
AstraZeneca’s Alexion inks AAV capsid deal with JCR Pharmanews2025-07-09T11:07:05+00:00July 9th, 2025|Endpoints News|
‘CRISPR Cures’ center launches to make custom gene editing therapiesnews2025-07-08T19:59:53+00:00July 8th, 2025|Endpoints News|
ProKidney’s stock shoots higher after mixed Phase 2 datanews2025-07-08T13:57:37+00:00July 8th, 2025|Endpoints News|
Startup raises $45M for universal flu vaccines made with mRNAnews2025-07-08T13:00:52+00:00July 8th, 2025|Endpoints News|
SCG Cell Therapy gets China thumbs-up for study of potentially curative HBV treatmentnews2025-07-08T11:17:10+00:00July 8th, 2025|Endpoints News|
Doctors sue RFK Jr., HHS over changes to Covid-19 vaccine schedulenews2025-07-07T19:34:38+00:00July 7th, 2025|Endpoints News|
Cogent’s mastocytosis drug hits ‘home run’ in registrational mid-stage trialnews2025-07-07T15:20:54+00:00July 7th, 2025|Endpoints News|
Compromised drug lot impacts Jasper’s chronic hives study, stock fallsnews2025-07-07T14:39:41+00:00July 7th, 2025|Endpoints News|
Apogee reports Phase 2 success for IL-13 drug in eczemanews2025-07-07T11:06:15+00:00July 7th, 2025|Endpoints News|
